Antiapoptotic function of 17AA(+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway
Antiapoptotic function of 17AA(+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway
复制标题
DOI:
10.1038/sj.onc.1209455
复制
发表时间:
2006-07-01
期刊:
影响因子:
8
通讯作者:
Sugiyama, H.
中科院分区:
文献类型:
--
作者:
Ito, K.;Oji, Y.;Sugiyama, H.
The WT1 gene is overexpressed in human primary leukemia and a wide variety of solid cancers. The WT1 gene is alternatively spliced at two sites, yielding four isoforms: 17AA(+) KTS(+), 17AA(+) KTS(-), 17AA(-) KTS(+), and 17AA(-) KTS(-). Here, we showed that 17AA(+) WT1-specific siRNA induced apoptosis in three WT1-expressing leukemia cell lines (K562, HL-60, and Kasumi-1), but not in WT1-nonexpressing lymphoma cell line (Daudi). 17AA(+) WT1-specific siRNA activated caspase- 3 and - 9 in the intrinsic apoptosis pathway but not caspase- 8 in the extrinsic one. On the other hand, 17AA(-) WT1-specific siRNA did not induce apoptosis in the three WT1-expressing cell lines. The apoptosis was associated with activation of proapoptotic Bax, which was activated upstream of the mitochondria. Constitutive expression of 17AA(+) WT1 isoforms inhibited apoptosis of K562 leukemia cells induced by apoptosis-inducing agents, etoposide and doxorubicin, through the protection of mitochondrial membrane damages, and DNA-binding zinc-finger region of 17AA(+) WT1 isoform was essential for the antiapoptotic functions. We further studied the gene(s) whose expression was altered by the expression of 17AA(+) WT1 isoforms and showed that the expression of proapoptotic Bak was decreased by the expression of 17AA(+) KTS(-) WT1 isoform. Taken together, these results indicated that 17AA(+) WT1 isoforms played antiapoptotic roles at some points upstream of the mitochondria in the intrinsic apoptosis pathway.